CompletedNot Applicable

Reduction of Mechanical IV Complication Using a New Medical Device

Sweden200 participantsStarted 2023-05-04

Plain-language summary

Peripheral intravenous catheters are necessary for in-hospital medical treatment. Malfunction due to occlusion or dislodgement is common, and increases the burden on health care. The aim of this study is to determine if the use of a new medical device has an impact on mechanical complications rate when peripheral intravenous (IV) catheter is used. The study will also investigate the safety, opinions of healthcare personnel and health economic effects of this new device,

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient has or will get a PIVC expected to be used for continuous or intermittent IV infusion therapy. Continuous IV infusion is defined as an infusion ≥ 2h and intermittent as an infusion lasting 15min to \< 2h. * ≥18 years of age * Speaks and understands Swedish Exclusion Criteria: * The PIVC is expected to be used for sampling only * Pregnancy * Unable to obtain informed consent or without an available Next-of-kin to provide surrogate informed consent * Patients under palliative care * Bolus IV infusion, defined as an infusion time of \<15 min * Phlebitis, infiltration or occlusion associated with PIVC that is already in place at the time of inclusion

What they're measuring

The rate of mechanical complications of an IV therapy session using a new medical device (ReLink) compared to using current 'state of the art'.

Timeframe: Up to one week from randomization

Trial details

NCT IDNCT05814887

SponsorUppsala University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-12

View on ClinicalTrials.gov More Catheter Complications trials